ED
BPMC
Exane Derivatives’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $404 | Sell |
8
-559
| -99% | -$28.2K | ﹤0.01% | 595 |
|
|
2022
Q1 | $36.2K | Buy |
567
+178
| +46% | +$11.4K | 0.01% | 604 |
|
|
2021
Q4 | $41.7K | Buy |
389
+362
| +1,341% | +$38.8K | 0.01% | 508 |
|
|
2021
Q3 | $2.78K | Hold |
27
| – | – | ﹤0.01% | 761 |
|
|
2021
Q2 | $2.23K | Hold |
27
| – | – | ﹤0.01% | 793 |
|
|
2021
Q1 | $2.63K | Hold |
27
| – | – | ﹤0.01% | 642 |
|
|
2020
Q4 | $3.03K | Hold |
27
| – | – | ﹤0.01% | 577 |
|
|
2020
Q3 | $2.5K | Hold |
27
| – | – | ﹤0.01% | 521 |
|
|
2020
Q2 | $2.11K | Sell |
27
-1,743
| -98% | -$136K | ﹤0.01% | 479 |
|
|
2020
Q1 | $104K | Buy |
1,770
+1,765
| +35,300% | +$103K | 0.03% | 261 |
|
|
2019
Q4 | $401 | Hold |
5
| – | – | ﹤0.01% | 600 |
|
|
2019
Q3 | $367 | Hold |
5
| – | – | ﹤0.01% | 575 |
|
|
2019
Q2 | $471 | Sell |
5
-90
| -95% | -$8.48K | ﹤0.01% | 575 |
|
|
2019
Q1 | $7.6K | Buy |
95
+82
| +631% | +$6.56K | ﹤0.01% | 382 |
|
|
2018
Q4 | $701 | Hold |
13
| – | – | ﹤0.01% | 548 |
|
|
2018
Q3 | $1.02K | Sell |
13
-1,449
| -99% | -$114K | ﹤0.01% | 498 |
|
|
2018
Q2 | $90.7K | Hold |
1,462
| – | – | 0.02% | 319 |
|
|
2018
Q1 | $127K | Buy |
+1,462
| New | +$127K | 0.03% | 261 |
|